Humoral
Showing 1 - 25 of 1,964
Humoral Rejection After Kidney Transplantation
Not yet recruiting
- Kidney Transplantation
- +3 more
- Blood draw, Urine draw
- (no location specified)
Jun 6, 2023
Immunosuppression, COVID-19 Trial in Madison (NVX-CoV2372)
Not yet recruiting
- Immunosuppression
- COVID-19
- NVX-CoV2372
-
Madison, WisconsinUW School of Medicine and Public Health
Aug 31, 2023
Chronic Histiocytic Intervillositis, Intrauterine Growth Retardation, Fetal Death in Utero Trial in Clamart (Biological
Not yet recruiting
- Chronic Histiocytic Intervillositis
- +3 more
- Biological collection
-
Clamart, FranceAntoine Béclère Hospital
Jun 30, 2023
Brain Metastases Trial (biological samples (blood test and lumbar puncture))
Not yet recruiting
- Brain Metastases
- biological samples (blood test and lumbar puncture)
- (no location specified)
May 4, 2023
Neuron-specific Humoral and Cellular Immune Correlates of
Recruiting
- Systemic Lupus Erythematosus
- MRI
-
Milano, ItalyIRCCS Ospedale San Raffaele
May 18, 2023
Humoral Immunity Trial in Gomel (Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by
Enrolling by invitation
- Humoral Immunity
- Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
-
Gomel, BelarusGomel State Medical University
Jan 30, 2023
Influenza, Human Trial in Philadelphia (Seasonal influenza vaccine)
Recruiting
- Influenza, Human
- Seasonal influenza vaccine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 17, 2022
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in
Active, not recruiting
- SARS-CoV-2 RNA Vaccines
- HIV Infection
- SARS-CoV-2 Vaccine
-
Sevilla, SpainVirgen del Rocio University Hospital
Dec 1, 2022
Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))
Not yet recruiting
- Secondary Antibody Deficiency
- Immunoglobulin replacement therapy (IGRT)
- (no location specified)
Nov 4, 2022
SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among
Completed
- SARS-CoV2 Infection
- +3 more
- IM injection of vaccination (mRNA vaccination)
- IM injection of vaccination (vector based vaccination)
-
Hildesheim, Niedersachsen, GermanyHelios Hospital Hildesheim
Dec 29, 2022
COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)
Not yet recruiting
- COPD Exacerbation Acute
- CUVITRU - Ig subcutaneous human 20%
- Standard Medical Therapy
-
Rochester, New York
- +2 more
Feb 28, 2023
Anti-COVID-19 Humoral and Memory T Cell Responses in Various
Active, not recruiting
- Immune Response
- blood collection
-
Paris, FranceHôpital Robert Debré
Sep 15, 2022
Immune Deficiency Trial in Charlottesville (Salmonella typhi polysaccharide vaccine)
Recruiting
- Immune Deficiency
- Salmonella typhi polysaccharide vaccine
-
Charlottesville, VirginiaUniversity of Virginia Health System
May 16, 2022
Humoral and Cellular Immunity in First-cycle SARS-CoV-2
Completed
- SARS CoV 2 Infection
- COVID-19
- LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)
- +2 more
-
Catanzaro, ItalyAOU Mater Domini
Jul 15, 2022
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
Active, not recruiting
- COVID-19
- +2 more
- Blood sample
-
London, United Kingdom
- +1 more
Aug 8, 2022
COVID-19 Vaccines in Immunocompromised and Healthy Individuals
Recruiting
- Covid19
- Immunosuppression
- Blood sample
- Saliva sample
-
Graz, AustriaMedical University of Graz
May 9, 2022
Host Genetic Factors Underlying Ebola Virus Disease Risk,
Completed
- Ebola Virus Disease
-
Kalkata, Liberia
- +3 more
Aug 18, 2022
Dynamics of Humoral and Cellular Immunity in COVID-19 Patients
Completed
- Covid19
- Humoral and cellular immunity
-
Minsk, BelarusInstitute of Biophysics and Cell Engineering of National Academy
Dec 9, 2021
Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in
Recruiting
- Diffuse Large-Cell Lymphoma
- +3 more
- Pneumococcal conjugate vaccine (PCV13)
- CD19 targeted CAR T Cell Therapy
-
Tampa, FloridaMoffitt Cancer Center
May 31, 2022
Cancer Trial in Dijon (serology and ELISPOT test, serology)
Recruiting
- Cancer
- serology and ELISPOT test
- serology
-
Dijon, FranceCentre Georges Francois Leclerc
Mar 24, 2022
Pertussis Immunization During Pregnancy & HIV Infection
Completed
- Immunization; Infection
- +3 more
- TDaP
-
Brussels, Belgium
- +1 more
Sep 29, 2022
Vaccine Reaction Trial in Venice-Lido (blood sample collection)
Active, not recruiting
- Vaccine Reaction
- blood sample collection
-
Venice-Lido, ItalyIRCCS San Camillo
Aug 24, 2022
Whether Osteocrin Levels Are Associated With Glycemic Control, Vascular Disorders in Diabetic Patients Trial in Assiut
Recruiting
- Whether Osteocrin Levels Are Associated With Glycemic Control, Vascular Disorders in Diabetic Patients
- osteocrin
-
Assiut, Egyptwalaa soliman Hussien
Jan 31, 2023
Tick Borne Encephalitis Trial in Vienna (TBE virus vaccine)
Completed
- Tick Borne Encephalitis
- TBE virus vaccine
-
Vienna, AustriaMedical University of Vienna, Department of Medicine I, Division
Jan 27, 2022
Common Variable Immunodeficiency and Related Syndromes
Recruiting
- CVID
- XLA
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023